| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.609 | 0.012 | 0.609 | Spasmolytic | 0.609 0.012 DBMET01446 | ||
| 0.557 | 0.01 | 0.557 | Cardiotonic | 0.557 0.01 DBMET01446 | ||
| 0.529 | 0.004 | 0.529 | Cholinergic antagonist | 0.529 0.004 DBMET01446 | ||
| 0.526 | 0.004 | 0.526 | Acetylcholine antagonist | 0.526 0.004 DBMET01446 | ||
| 0.514 | 0.045 | 0.514 | Analgesic | 0.514 0.045 DBMET01446 | ||
| 0.487 | 0.054 | 0.487 | Cyclophilin D inhibitor | 0.487 0.054 DBMET01446 | ||
| 0.465 | 0.039 | 0.465 | Toll-Like receptor 7 agonist | 0.465 0.039 DBMET01446 | ||
| 0.456 | 0.042 | 0.456 | Toll-Like receptor agonist | 0.456 0.042 DBMET01446 | ||
| 0.426 | 0.018 | 0.426 | Sigma receptor agonist | 0.426 0.018 DBMET01446 | ||
| 0.417 | 0.014 | 0.417 | Anesthetic general | 0.417 0.014 DBMET01446 | ||
| 0.445 | 0.048 | 0.445 | Immunosuppressant | 0.445 0.048 DBMET01446 | ||
| 0.391 | 0.005 | 0.391 | Acetylcholine muscarinic antagonist | 0.391 0.005 DBMET01446 | ||
| 0.37 | 0.048 | 0.37 | Nootropic | 0.37 0.048 DBMET01446 | ||
| 0.354 | 0.037 | 0.354 | Tumour necrosis factor alpha release inhibitor | 0.354 0.037 DBMET01446 | ||
| 0.313 | 0.004 | 0.313 | Acetylcholine M3 receptor antagonist | 0.313 0.004 DBMET01446 | ||
| 0.296 | 0.015 | 0.296 | Acetylcholine M1 receptor antagonist | 0.296 0.015 DBMET01446 | ||
| 0.333 | 0.061 | 0.333 | 5 Hydroxytryptamine release stimulant | 0.333 0.061 DBMET01446 | ||
| 0.333 | 0.096 | 0.333 | Antiobesity | 0.333 0.096 DBMET01446 | ||
| 0.308 | 0.072 | 0.308 | Sodium/bile acid cotransporter inhibitor | 0.308 0.072 DBMET01446 | ||
| 0.312 | 0.08 | 0.312 | Calcium channel activator | 0.312 0.08 DBMET01446 | ||
| 0.282 | 0.053 | 0.282 | Potassium channel blocker | 0.282 0.053 DBMET01446 | ||
| 0.309 | 0.085 | 0.309 | Cholesterol antagonist | 0.309 0.085 DBMET01446 | ||
| 0.303 | 0.085 | 0.303 | Vasodilator, coronary | 0.303 0.085 DBMET01446 | ||
| 0.303 | 0.095 | 0.303 | Vasodilator, peripheral | 0.303 0.095 DBMET01446 | ||
| 0.261 | 0.058 | 0.261 | Cyclic AMP phosphodiesterase inhibitor | 0.261 0.058 DBMET01446 | ||
| 0.217 | 0.016 | 0.217 | Bronchodilator | 0.217 0.016 DBMET01446 | ||
| 0.211 | 0.012 | 0.211 | Acetylcholine nicotinic antagonist | 0.211 0.012 DBMET01446 | ||
| 0.222 | 0.026 | 0.222 | Anesthetic local | 0.222 0.026 DBMET01446 | ||
| 0.345 | 0.15 | 0.345 | Caspase 9 stimulant | 0.345 0.15 DBMET01446 | ||
| 0.264 | 0.068 | 0.264 | 5 Hydroxytryptamine uptake stimulant | 0.264 0.068 DBMET01446 | ||
| 0.195 | 0.005 | 0.195 | Acetylcholine M3 receptor agonist | 0.195 0.005 DBMET01446 | ||
| 0.279 | 0.09 | 0.279 | Interleukin 2 agonist | 0.279 0.09 DBMET01446 | ||
| 0.223 | 0.037 | 0.223 | Cholinergic | 0.223 0.037 DBMET01446 | ||
| 0.352 | 0.171 | 0.352 | Antiinflammatory | 0.352 0.171 DBMET01446 | ||
| 0.282 | 0.101 | 0.282 | Antithrombotic | 0.282 0.101 DBMET01446 | ||
| 0.226 | 0.05 | 0.226 | P-glycoprotein inhibitor | 0.226 0.05 DBMET01446 | ||
| 0.167 | 0.004 | 0.167 | Sigma 2 receptor antagonist | 0.167 0.004 DBMET01446 | ||
| 0.237 | 0.074 | 0.237 | Potassium channel (Voltage-sensitive) blocker | 0.237 0.074 DBMET01446 | ||
| 0.237 | 0.076 | 0.237 | Angiogenesis stimulant | 0.237 0.076 DBMET01446 | ||
| 0.175 | 0.017 | 0.175 | Phosphodiesterase IV inhibitor | 0.175 0.017 DBMET01446 | ||
| 0.24 | 0.083 | 0.24 | Hypoglycemic | 0.24 0.083 DBMET01446 | ||
| 0.235 | 0.079 | 0.235 | Platelet antagonist | 0.235 0.079 DBMET01446 | ||
| 0.192 | 0.037 | 0.192 | Alpha-N-acetylglucosaminidase inhibitor | 0.192 0.037 DBMET01446 | ||
| 0.234 | 0.079 | 0.234 | Vasodilator | 0.234 0.079 DBMET01446 | ||
| 0.185 | 0.035 | 0.185 | Neurotrophic factor | 0.185 0.035 DBMET01446 | ||
| 0.155 | 0.005 | 0.155 | Opioid kappa receptor agonist | 0.155 0.005 DBMET01446 | ||
| 0.152 | 0.011 | 0.152 | Acetylcholine M2 receptor antagonist | 0.152 0.011 DBMET01446 | ||
| 0.226 | 0.087 | 0.226 | DNA synthesis inhibitor | 0.226 0.087 DBMET01446 | ||
| 0.141 | 0.011 | 0.141 | Dopamine uptake inhibitor | 0.141 0.011 DBMET01446 | ||
| 0.133 | 0.005 | 0.133 | Neurokinin 1 antagonist | 0.133 0.005 DBMET01446 | ||
| 0.152 | 0.025 | 0.152 | Nav1.5 sodium channel blocker | 0.152 0.025 DBMET01446 | ||
| 0.157 | 0.033 | 0.157 | Expectorant | 0.157 0.033 DBMET01446 | ||
| 0.128 | 0.007 | 0.128 | Neurokinin antagonist | 0.128 0.007 DBMET01446 | ||
| 0.162 | 0.041 | 0.162 | Alkylator | 0.162 0.041 DBMET01446 | ||
| 0.134 | 0.019 | 0.134 | Interleukin 12 antagonist | 0.134 0.019 DBMET01446 | ||
| 0.204 | 0.091 | 0.204 | Hypolipemic | 0.204 0.091 DBMET01446 | ||
| 0.168 | 0.058 | 0.168 | Interferon gamma antagonist | 0.168 0.058 DBMET01446 | ||
| 0.18 | 0.072 | 0.18 | Amyloid beta precursor protein antagonist | 0.18 0.072 DBMET01446 | ||
| 0.241 | 0.134 | 0.241 | Transcription factor NF kappa B inhibitor | 0.241 0.134 DBMET01446 | ||
| 0.128 | 0.021 | 0.128 | Opioid kappa receptor antagonist | 0.128 0.021 DBMET01446 | ||
| 0.113 | 0.014 | 0.113 | Acetylcholine M5 receptor agonist | 0.113 0.014 DBMET01446 | ||
| 0.112 | 0.015 | 0.112 | Sigma receptor antagonist | 0.112 0.015 DBMET01446 | ||
| 0.109 | 0.013 | 0.109 | Beta adrenoreceptor antagonist | 0.109 0.013 DBMET01446 | ||
| 0.11 | 0.015 | 0.11 | Acetylcholine muscarinic agonist | 0.11 0.015 DBMET01446 | ||
| 0.204 | 0.111 | 0.204 | Antioxidant | 0.204 0.111 DBMET01446 | ||
| 0.203 | 0.114 | 0.203 | Superoxide dismutase inhibitor | 0.203 0.114 DBMET01446 | ||
| 0.107 | 0.017 | 0.107 | Glycine receptor agonist | 0.107 0.017 DBMET01446 | ||
| 0.13 | 0.042 | 0.13 | Antiadrenergic | 0.13 0.042 DBMET01446 | ||
| 0.205 | 0.117 | 0.205 | Immunostimulant | 0.205 0.117 DBMET01446 | ||
| 0.103 | 0.018 | 0.103 | Potassium channel Kv1.5 blocker | 0.103 0.018 DBMET01446 | ||
| 0.095 | 0.011 | 0.095 | Beta 1 adrenoreceptor antagonist | 0.095 0.011 DBMET01446 | ||
| 0.126 | 0.042 | 0.126 | Adrenaline antagonist | 0.126 0.042 DBMET01446 | ||
| 0.122 | 0.042 | 0.122 | Toll-Like receptor 4 antagonist | 0.122 0.042 DBMET01446 | ||
| 0.084 | 0.007 | 0.084 | Substance P antagonist | 0.084 0.007 DBMET01446 | ||
| 0.116 | 0.039 | 0.116 | Antineoplastic alkaloid | 0.116 0.039 DBMET01446 | ||
| 0.105 | 0.029 | 0.105 | Analgesic, opioid | 0.105 0.029 DBMET01446 | ||
| 0.101 | 0.025 | 0.101 | Phosphodiesterase 4B inhibitor | 0.101 0.025 DBMET01446 | ||
| 0.167 | 0.092 | 0.167 | Hepatoprotectant | 0.167 0.092 DBMET01446 | ||
| 0.114 | 0.039 | 0.114 | Acetylcholine agonist | 0.114 0.039 DBMET01446 | ||
| 0.102 | 0.027 | 0.102 | Acetylcholine M4 receptor antagonist | 0.102 0.027 DBMET01446 | ||
| 0.085 | 0.011 | 0.085 | Acetylcholine M2 receptor agonist | 0.085 0.011 DBMET01446 | ||
| 0.082 | 0.007 | 0.082 | Sigma 1 receptor antagonist | 0.082 0.007 DBMET01446 | ||
| 0.165 | 0.092 | 0.165 | Platelet adhesion inhibitor | 0.165 0.092 DBMET01446 | ||
| 0.084 | 0.012 | 0.084 | Calcium channel P-type blocker | 0.084 0.012 DBMET01446 | ||
| 0.082 | 0.01 | 0.082 | Alpha-mannosidase inhibitor | 0.082 0.01 DBMET01446 | ||
| 0.092 | 0.022 | 0.092 | MAP kinase kinase 7 inhibitor | 0.092 0.022 DBMET01446 | ||
| 0.144 | 0.074 | 0.144 | Adenylate cyclase stimulant | 0.144 0.074 DBMET01446 | ||
| 0.088 | 0.02 | 0.088 | Androgen agonist | 0.088 0.02 DBMET01446 | ||
| 0.083 | 0.015 | 0.083 | Acetylcholine M1 receptor agonist | 0.083 0.015 DBMET01446 | ||
| 0.133 | 0.071 | 0.133 | Phosphodiesterase inhibitor | 0.133 0.071 DBMET01446 | ||
| 0.132 | 0.07 | 0.132 | Interleukin 4 antagonist | 0.132 0.07 DBMET01446 | ||
| 0.262 | 0.202 | 0.262 | Apoptosis agonist | 0.262 0.202 DBMET01446 | ||
| 0.098 | 0.038 | 0.098 | Phosphodiesterase 4D inhibitor | 0.098 0.038 DBMET01446 | ||
| 0.211 | 0.151 | 0.211 | Immunomodulator | 0.211 0.151 DBMET01446 | ||
| 0.077 | 0.018 | 0.077 | Dopamine transporter inhibitor | 0.077 0.018 DBMET01446 | ||
| 0.076 | 0.018 | 0.076 | Glucosylceramidase inhibitor | 0.076 0.018 DBMET01446 | ||
| 0.076 | 0.018 | 0.076 | Sphingosine kinase 2 inhibitor | 0.076 0.018 DBMET01446 | ||
| 0.099 | 0.041 | 0.099 | ATPase (Vacuolar H+) inhibitor | 0.099 0.041 DBMET01446 | ||
| 0.15 | 0.094 | 0.15 | Nitric oxide antagonist | 0.15 0.094 DBMET01446 | ||
| 0.086 | 0.032 | 0.086 | Neuronal nicotinic receptor antagonist | 0.086 0.032 DBMET01446 | ||
| 0.062 | 0.01 | 0.062 | Guanylate cyclase inhibitor | 0.062 0.01 DBMET01446 | ||
| 0.1 | 0.048 | 0.1 | Opioid antagonist | 0.1 0.048 DBMET01446 | ||
| 0.074 | 0.021 | 0.074 | Opioid agonist | 0.074 0.021 DBMET01446 | ||
| 0.065 | 0.014 | 0.065 | Mannosidase inhibitor | 0.065 0.014 DBMET01446 | ||
| 0.073 | 0.022 | 0.073 | Sphingosine kinase inhibitor | 0.073 0.022 DBMET01446 | ||
| 0.125 | 0.076 | 0.125 | Vanilloid 1 agonist | 0.125 0.076 DBMET01446 | ||
| 0.112 | 0.063 | 0.112 | Mucolytic | 0.112 0.063 DBMET01446 | ||
| 0.126 | 0.078 | 0.126 | Sodium channel (voltage-gated) blocker | 0.126 0.078 DBMET01446 | ||
| 0.11 | 0.062 | 0.11 | Electron transport complex I inhibitor | 0.11 0.062 DBMET01446 | ||
| 0.115 | 0.069 | 0.115 | Cholesterol synthesis inhibitor | 0.115 0.069 DBMET01446 | ||
| 0.145 | 0.101 | 0.145 | Antipruritic | 0.145 0.101 DBMET01446 | ||
| 0.068 | 0.026 | 0.068 | NMDA 2B receptor antagonist | 0.068 0.026 DBMET01446 | ||
| 0.113 | 0.074 | 0.113 | DNA polymerase I inhibitor | 0.113 0.074 DBMET01446 | ||
| 0.066 | 0.028 | 0.066 | Beta 2 adrenoreceptor agonist | 0.066 0.028 DBMET01446 | ||
| 0.165 | 0.128 | 0.165 | Free radical scavenger | 0.165 0.128 DBMET01446 | ||
| 0.072 | 0.035 | 0.072 | 5 Hydroxytryptamine 2A agonist | 0.072 0.035 DBMET01446 | ||
| 0.085 | 0.049 | 0.085 | T cell inhibitor | 0.085 0.049 DBMET01446 | ||
| 0.04 | 0.004 | 0.04 | 1,3-Beta-glucan synthase inhibitor | 0.04 0.004 DBMET01446 | ||
| 0.047 | 0.012 | 0.047 | Acetylcholine M4 receptor agonist | 0.047 0.012 DBMET01446 | ||
| 0.101 | 0.069 | 0.101 | AMP-activated protein kinase stimulant | 0.101 0.069 DBMET01446 | ||
| 0.146 | 0.114 | 0.146 | Phospholipase C inhibitor | 0.146 0.114 DBMET01446 | ||
| 0.044 | 0.012 | 0.044 | Ceramide glucosyltransferase inhibitor | 0.044 0.012 DBMET01446 | ||
| 0.176 | 0.143 | 0.176 | Interleukin agonist | 0.176 0.143 DBMET01446 | ||
| 0.136 | 0.104 | 0.136 | Melanin inhibitor | 0.136 0.104 DBMET01446 | ||
| 0.082 | 0.055 | 0.082 | Adrenaline agonist | 0.082 0.055 DBMET01446 | ||
| 0.041 | 0.019 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.041 0.019 DBMET01446 | ||
| 0.045 | 0.023 | 0.045 | Sphingosine kinase 1 inhibitor | 0.045 0.023 DBMET01446 | ||
| 0.083 | 0.062 | 0.083 | mTOR complex 2 inhibitor | 0.083 0.062 DBMET01446 | ||
| 0.081 | 0.062 | 0.081 | Estrogen-related receptor beta agonist | 0.081 0.062 DBMET01446 | ||
| 0.052 | 0.034 | 0.052 | 5 Hydroxytryptamine 4 antagonist | 0.052 0.034 DBMET01446 | ||
| 0.086 | 0.071 | 0.086 | Breast cancer-resistant protein inhibitor | 0.086 0.071 DBMET01446 | ||
| 0.065 | 0.049 | 0.065 | Opioid mu receptor antagonist | 0.065 0.049 DBMET01446 | ||
| 0.167 | 0.152 | 0.167 | Peptidyltransferase inhibitor | 0.167 0.152 DBMET01446 | ||
| 0.059 | 0.044 | 0.059 | Acetylcholine M5 receptor antagonist | 0.059 0.044 DBMET01446 | ||
| 0.075 | 0.061 | 0.075 | Antineoplastic antibiotic | 0.075 0.061 DBMET01446 | ||
| 0.107 | 0.094 | 0.107 | Cyclooxygenase 3 inhibitor | 0.107 0.094 DBMET01446 | ||
| 0.113 | 0.101 | 0.113 | Protein kinase stimulant | 0.113 0.101 DBMET01446 | ||
| 0.096 | 0.085 | 0.096 | Multidrug resistance-associated protein 1 inhibitor | 0.096 0.085 DBMET01446 | ||
| 0.146 | 0.135 | 0.146 | HERG channel blocker | 0.146 0.135 DBMET01446 | ||
| 0.081 | 0.071 | 0.081 | Alpha adrenoreceptor antagonist | 0.081 0.071 DBMET01446 | ||
| 0.029 | 0.022 | 0.029 | Thiazolidinedione | 0.029 0.022 DBMET01446 | ||
| 0.18 | 0.175 | 0.18 | Tyrosine 3 hydroxylase inhibitor | 0.18 0.175 DBMET01446 | ||
| 0.029 | 0.025 | 0.029 | Cholesterol ester transfer protein antagonist | 0.029 0.025 DBMET01446 | ||
| 0.038 | 0.034 | 0.038 | Acetyl-CoA carboxylase inhibitor | 0.038 0.034 DBMET01446 | ||
| 0.018 | 0.015 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.015 DBMET01446 | ||
| 0.038 | 0.035 | 0.038 | Plasmepsin II inhibitor | 0.038 0.035 DBMET01446 | ||
| 0.032 | 0.029 | 0.032 | Tubulin agonist | 0.032 0.029 DBMET01446 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |